Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

ANDE May 6, 2026

The Andersons Q1 2026 Earnings Call - Record Profit Driven by Renewable Tax Credits and Ag Market Volatility

The Andersons delivered its strongest first quarter ever, generating record net income of $33 million and adjusted EPS of $1.12, a massive jump from the prior year’s near-breakeven performance. The re...

  • Record Financial Performance: The Andersons reported its strongest first quarter ever, with net income of $33 million ($0.97 diluted EPS) and adjusted EPS of $1.12, compared to just $0.12 adjusted EPS in Q1 2025.
  • Renewables Tax Credit Boost: The renewables segment generated $40 million in pre-tax income, significantly boosted by $26 million in 45Z producer tax credits recognized in Q1 2026.
  • Ag Market Volatility Pays Off: Agribusiness adjusted pre-tax income improved to $18 million from break-even in the prior year, as the company leveraged increased market volatility and supply disruptions to enhance merchandising and fertilizer margins.
  • +7 more takeaways
KD May 6, 2026

Kyndryl FY2026 Earnings Call - Agentic AI Modernization Drives Margin Expansion Despite IBM Headwinds

Kyndryl delivered a complex fiscal 2026, reporting flat revenue but strong margin expansion driven by its strategic pivot toward high-value services. The company generated over $400 million in free ca...

  • Kyndryl reported $15.1 billion in revenue for fiscal 2026, flat year-over-year on a reported basis, but delivered adjusted pre-tax income growth and margin expansion.
  • Hyperscaler-related revenue surged 59% to nearly $2 billion, exceeding initial targets and highlighting a successful strategic pivot away from legacy infrastructure dependencies.
  • Kyndryl Consult delivered double-digit revenue growth for the third consecutive year, with signings now exceeding revenue, signaling strong demand for high-value modernization services.
  • +9 more takeaways
HLLY May 6, 2026

Holley (HLLY) Q1 2026 Earnings Call - Portfolio Rebalancing and Margin Expansion Offset Weather Headwinds

Holley reported a mixed Q1 2026, with net sales declining 3.7% to $147.3 million due to elevated distributor inventories and severe winter weather that delayed retail activity. Despite the top-line pr...

  • Net sales declined 3.7% year-over-year to $147.3 million, driven by elevated distributor inventories and severe winter weather that delayed retail sell-through in January and February.
  • Adjusted EBITDA remained flat at $27.3 million year-over-year, but adjusted EBITDA margin expanded 71 basis points to 18.5%, reflecting disciplined cost control and operational efficiency.
  • Net income more than doubled to $7.3 million from $2.8 million in Q1 2025, as margin expansion and lower SG&A costs (down $1.4 million) offset revenue headwinds.
  • +12 more takeaways
SOLS May 6, 2026

Solstice Advanced Materials Q1 2026 Earnings Call - Nuclear and Semiconductor Demand Drive Strong Results

Solstice Advanced Materials reported a robust first quarter in 2026, delivering $991 million in net sales, up 10% year-over-year, and $249 million in adjusted EBITDA. The results were driven by strong...

  • Net sales reached $991 million, up 10% year-over-year, exceeding the top end of guidance.
  • Adjusted EBITDA was $249 million, flat year-over-year but above guidance, with a 25.1% margin.
  • Electronic materials sales surged 21% year-over-year, driven by robust semiconductor demand.
  • +7 more takeaways
ASTE May 6, 2026

Astec Industries Q1 2026 Earnings Call - Backlog Surges Amid Tariff Headwinds

Astec Industries reported a 20.3% year-over-year increase in first-quarter net sales to $1.47 billion, driven by strong demand in the Materials Solutions segment and contributions from recent acquisit...

  • First-quarter net sales surged 20.3% year-over-year to approximately $1.47 billion, reflecting strong organic growth and the impact of recent acquisitions.
  • Adjusted EBITDA for the quarter declined to $30.3 million, down from the prior year, due to timing effects, higher freight costs, and tariff-related inflation.
  • Full-year 2026 adjusted EBITDA guidance remains unchanged at $170 million to $190 million, with management expressing confidence in achieving targets.
  • +7 more takeaways
TWIN May 6, 2026

Twin Disc Incorporated Fiscal Third Quarter 2026 Earnings Call - Defense Backlog and Margin Expansion Drive Strong Q3 Results

Twin Disc delivered a robust fiscal third quarter 2026, with sales jumping 19% year-over-year to $96.7 million and EBITDA surging 135% to $9.4 million. The growth was fueled by strong demand in Marine...

  • Sales increased 19% year-over-year to $96.7 million, with organic growth of 7% excluding acquisitions and foreign exchange.
  • EBITDA surged 135% year-over-year to $9.4 million, with EBITDA margins expanding by approximately 480 basis points.
  • Gross margin improved to 28.1%, driven by higher volumes and successful margin improvement initiatives.
  • +11 more takeaways
TBLA May 6, 2026

Taboola Q1 2026 Earnings Call - Raised Full-Year Guidance on Realize Momentum and Share Buybacks

Taboola delivered a strong start to 2026, with Q1 results beating the high end of guidance across all metrics, driven by continued adoption of its AI-powered Realize platform. Revenue grew 9% year-ove...

  • Q1 2026 revenue grew 9% year-over-year to $466.4 million, beating the high end of guidance.
  • Ex-TAC gross profit increased 11% year-over-year to $168.1 million, reflecting strong advertiser spend and Realize adoption.
  • Management raised full-year guidance, now expecting revenue of $2.00 billion to $2.06 billion and ex-TAC gross profit of $760 million to $781 million.
  • +10 more takeaways
EYPT May 6, 2026

EyePoint Pharmaceuticals Q1 2026 Earnings Call - DURAVYU Phase III Momentum Accelerates as Cash Runway Extends to Late 2027

EyePoint Pharmaceuticals reported a sharp revenue drop to $0.7 million in Q1 2026 as deferred licensing fees from the YUTIQ deal concluded, while operating expenses rose to $88 million to fund two Pha...

  • Revenue fell to $0.7 million in Q1 2026 from $24.5 million in Q1 2025, driven by the conclusion of deferred revenue recognition from the 2023 YUTIQ licensing agreement.
  • Operating expenses increased to $88 million from $73 million in the prior year period, primarily due to ongoing Phase III trials for DURAVYU and scaling of the Northbridge commercial manufacturing facility.
  • The company reported a net loss of $85 million, or $0.99 per share, compared to a net loss of $45 million, or $0.65 per share, in the prior year period.
  • +9 more takeaways
TFPM May 6, 2026

Triple Flag Precious Metals Q1 2026 Earnings Call - Record Start Driven by High-Margin Cash Flow and Accretive U.S. Copper Royalty

Triple Flag Precious Metals delivered a historic first quarter, shattering records across every key metric with 30,000+ GEOs, $129 million in adjusted EBITDA, and a 67% surge in operating cash flow pe...

  • Q1 2026 marks the strongest quarter in company history across every key metric, including over 30,000 GEOs, $129 million in adjusted EBITDA, and $0.55 in operating cash flow per share.
  • Operating cash flow per share surged 67% year-over-year, driven by high-margin exposure to rising gold and silver prices and the model functioning as intended.
  • The company unlocked the high-grade E44 gold deposit at Northparkes, securing guaranteed minimum deliveries over seven years starting in 2030, aligning with Evolution Mining's block cave and mill expansion plans.
  • +8 more takeaways
CVS May 6, 2026

CVS Health Q1 2026 Earnings Call - EPS Guidance Raised to $7.30-$7.50 as Aetna Margins Recover

CVS Health delivered a strong first quarter, driving a 14% year-over-year increase in adjusted earnings per share to $2.57. The company responded to this momentum by raising its full-year 2026 adjuste...

  • Adjusted EPS of $2.57 beat expectations, driving a full-year 2026 guidance raise to $7.30-$7.50, up from $7.00-$7.20.
  • Revenue surged over 6% year-over-year to $100 billion, with adjusted operating income increasing 12% to $5.2 billion.
  • Aetna’s medical benefit ratio improved to 84.6% in Q1, reflecting strong medical cost management and favorable prior year development.
  • +12 more takeaways